finc.format ElectronicArticle
finc.mega_collection sid-55-col-jstorlife
sid-55-col-jstorhealth
JSTOR Life Sciences Archive
JSTOR Health & General Sciences
finc.id ai-55-aHR0cHM6Ly93d3cuanN0b3Iub3JnL3N0YWJsZS80MDcwMTkwMw
finc.source_id 55
ris.type EJOUR
rft.atitle Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau
rft.epage 749
rft.genre article
rft.issn 0959-8138
1756-1833
rft.issue 7749
rft.jtitle BMJ: British Medical Journal
rft.pages 749-749
rft.pub British Medical Association
rft.date 2010-04-03
x.date 2010-04-03T00:00:00Z
rft.spage 749
rft.volume 340
abstract <p>STUDY QUESTION Is intradermal BCG revaccination at 19 months of age after booster diphtheria-tetan us-pertussis (DTP) vaccination, usually administered at 18 months of age, associated with improved childhood survival? SUMMARY ANSWER There was no overall beneficial effect of BCG revaccination on survival in children. The mortality of BCG revaccinated children increased significantly during a short period when many children received missing vaccinations or vitamin A or iron supplementation in campaigns. WHAT IS KNOWN AND WHATTHIS PAPER ADDS BCG vaccination has stimulatory effects on the immune system, and previous studies have reported oral BCG revaccination to be associated with improved childhood survival. In this trial, BCG revaccination reduced mortality when given after booster DTP vaccination but mortality was increased among the children who were likely to receive DTP boostervaccination after BCG revaccination.</p>
authors Array ( [rft.aulast] => Roth [rft.aufirst] => Adam Edvin )
Array ( [rft.aulast] => Benn [rft.aufirst] => Christine Stabell )
Array ( [rft.aulast] => Ravn [rft.aufirst] => Henrik )
Array ( [rft.aulast] => Rodrigues [rft.aufirst] => Amabelia )
Array ( [rft.aulast] => Lisse [rft.aufirst] => Ida Maria )
Array ( [rft.aulast] => Yazdanbakhsh [rft.aufirst] => Maria )
Array ( [rft.aulast] => Whittle [rft.aufirst] => Hilton )
Array ( [rft.aulast] => Aaby [rft.aufirst] => Peter )
languages eng
url https://www.jstor.org/stable/40701903
version 0.9
x.subjects RESEARCH
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Effect+of+revaccination+with+BCG+in+early+childhood+on+mortality%3A+randomised+trial+in+Guinea-Bissau&rft.date=2010-04-03&genre=article&issn=1756-1833&volume=340&issue=7749&spage=749&epage=749&pages=749-749&jtitle=BMJ%3A+British+Medical+Journal&atitle=Effect+of+revaccination+with+BCG+in+early+childhood+on+mortality%3A+randomised+trial+in+Guinea-Bissau&aulast=Aaby&aufirst=Peter&rft.language%5B0%5D=eng
SOLR
_version_ 1792365404061958146
author Roth, Adam Edvin, Benn, Christine Stabell, Ravn, Henrik, Rodrigues, Amabelia, Lisse, Ida Maria, Yazdanbakhsh, Maria, Whittle, Hilton, Aaby, Peter
author_facet Roth, Adam Edvin, Benn, Christine Stabell, Ravn, Henrik, Rodrigues, Amabelia, Lisse, Ida Maria, Yazdanbakhsh, Maria, Whittle, Hilton, Aaby, Peter, Roth, Adam Edvin, Benn, Christine Stabell, Ravn, Henrik, Rodrigues, Amabelia, Lisse, Ida Maria, Yazdanbakhsh, Maria, Whittle, Hilton, Aaby, Peter
author_sort roth, adam edvin
collection sid-55-col-jstorlife, sid-55-col-jstorhealth
container_issue 7749
container_start_page 749
container_title BMJ: British Medical Journal
container_volume 340
description <p>STUDY QUESTION Is intradermal BCG revaccination at 19 months of age after booster diphtheria-tetan us-pertussis (DTP) vaccination, usually administered at 18 months of age, associated with improved childhood survival? SUMMARY ANSWER There was no overall beneficial effect of BCG revaccination on survival in children. The mortality of BCG revaccinated children increased significantly during a short period when many children received missing vaccinations or vitamin A or iron supplementation in campaigns. WHAT IS KNOWN AND WHATTHIS PAPER ADDS BCG vaccination has stimulatory effects on the immune system, and previous studies have reported oral BCG revaccination to be associated with improved childhood survival. In this trial, BCG revaccination reduced mortality when given after booster DTP vaccination but mortality was increased among the children who were likely to receive DTP boostervaccination after BCG revaccination.</p>
facet_avail Online
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-55-aHR0cHM6Ly93d3cuanN0b3Iub3JnL3N0YWJsZS80MDcwMTkwMw
imprint British Medical Association, 2010
imprint_str_mv British Medical Association, 2010
institution DE-15, DE-14, DE-D13
issn 0959-8138, 1756-1833
issn_str_mv 0959-8138, 1756-1833
language English
last_indexed 2024-03-01T22:40:51.455Z
match_str roth2010effectofrevaccinationwithbcginearlychildhoodonmortalityrandomisedtrialinguineabissau
mega_collection JSTOR Life Sciences Archive, JSTOR Health & General Sciences
physical 749-749
publishDate 2010
publishDateSort 2010
publisher British Medical Association
record_format ai
recordtype ai
score 18,864033
series BMJ: British Medical Journal
source_id 55
spelling Roth, Adam Edvin Benn, Christine Stabell Ravn, Henrik Rodrigues, Amabelia Lisse, Ida Maria Yazdanbakhsh, Maria Whittle, Hilton Aaby, Peter 0959-8138 1756-1833 British Medical Association RESEARCH https://www.jstor.org/stable/40701903 <p>STUDY QUESTION Is intradermal BCG revaccination at 19 months of age after booster diphtheria-tetan us-pertussis (DTP) vaccination, usually administered at 18 months of age, associated with improved childhood survival? SUMMARY ANSWER There was no overall beneficial effect of BCG revaccination on survival in children. The mortality of BCG revaccinated children increased significantly during a short period when many children received missing vaccinations or vitamin A or iron supplementation in campaigns. WHAT IS KNOWN AND WHATTHIS PAPER ADDS BCG vaccination has stimulatory effects on the immune system, and previous studies have reported oral BCG revaccination to be associated with improved childhood survival. In this trial, BCG revaccination reduced mortality when given after booster DTP vaccination but mortality was increased among the children who were likely to receive DTP boostervaccination after BCG revaccination.</p> Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau BMJ: British Medical Journal
spellingShingle Roth, Adam Edvin, Benn, Christine Stabell, Ravn, Henrik, Rodrigues, Amabelia, Lisse, Ida Maria, Yazdanbakhsh, Maria, Whittle, Hilton, Aaby, Peter, BMJ: British Medical Journal, Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau, RESEARCH
title Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau
title_full Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau
title_fullStr Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau
title_full_unstemmed Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau
title_short Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau
title_sort effect of revaccination with bcg in early childhood on mortality: randomised trial in guinea-bissau
title_unstemmed Effect of revaccination with BCG in early childhood on mortality: randomised trial in Guinea-Bissau
topic RESEARCH
url https://www.jstor.org/stable/40701903